Danish Healthtech er medfinansieret af Uddannelses- og Forsknings-ministeriet og Den Europæiske Fond for Regionaludvikling.

Collaborative Projects

The Innovation Network Danish Healthtech offers collaborative projects with the aim of strengthening companies’ interaction and knowledge exchange with universities and Danish government-approved Research and Technology Organisations and thereby increasing innovation and growth potential.

On this page, we regularly announce new collaboration opportunities within the themes:

  • Better and cheaper prevention, diagnostics and treatment
  • Citizen-related and technology-supported healthcare
  • Physical and mental health
  • Personal treatment with a focus on health technology equipment

Below you will find a selection of the ongoing and previous collaborative projects.  

Please don’t hesitate to contact us, if you would like to participate in a project: contact@danishhealthtech.dk

Following requirements apply when you engage in a collaborative project:

  • The projects must have participation by at least two independent companies and at least one knowledge institution.
  • The projects must relate to the innovation network’s professional focus areas and contribute to meet the network’s objectives.
  • The projects must be based on the companies’ specific needs, support the dissemination and utilization of the knowledge institutions’ knowledge and competencies as well as the joint development of new knowledge by the parties.
  • In the collaboration projects, the parties involved make a written agreement in content, expectations for time consumption and expected results. It does not cost companies to participate beyond their own working hours.

Opportunities for collaboration

Equality in health services through innovative technology

Development and testing of central nervous system hyperactivity measurement apparatus in chronic pain patients

This project aims to develop new technologies that support equality in healthcare services for the benefit of the most deprived citizens and innovative companies seeking this potentially large market.

Innovative health technologies have the potential to improve public health for everyone. However, we tend to design systems for people like us – the privileged ones. The morbidity rates are higher among low income groups, non-educated, etc. (the 3 Ds: “disengaged, disconnected, and disempowered”).

This project will propose innovative e-health technology solutions that support equality in health services – ie. provision of technology and services aimed at disadvantaged citizens.

  • An idea catalog of innovative healthcare technology solutions that support equality in health services
  • A prototype solution that demonstrates the potential.

January 2019 – December 2019

Participation in open workshop in June 2019 – calendar on the website.

Innovative health technology companies that have solutions in the field are welcome to contact the project manager before July 1st 2019.

University of Southern Denmark. Project manager: Camilla Panduro Nielsen capn@mmmi.sdu.dk

Svendborg Municipality, University Hospital of Odense, Welfare Tech. Private companies.

20% of the world’s population suffers from chronic pain. The central nervous system can become hyperactive in prolonged pain. The degree of hyperactivity is associated with the risk of chronic pain after surgery or limited analgesic effect of pharmacological treatments.

Research has developed methods to measure this hyperactivity, but these are often slow, economically heavy and require different equipment. This means the methods are not suitable for clinical practice. A better product is needed.

The project will develop an apparatus for examining hyperactivity in the central nervous system. The device will be tested by a Good Clinical Practice (GCP): controlled trial of a drug that targets central nervous system hyperactivity. It will be investigated whether the degree of hyperactivity is related to the degree of analgesic effect.

The project will mature the technology, create results for the treatment of the hyperactive central nervous system and build up competences in the companies. Furthermore the project will provide a foundation for the concept “personalized pain medicine”, whose hyperactivity in the central nervous system can be treated, leading to a potential analgesic effect.

January 2019 – December 2020

A binding cooperation-agreement has been entered between the participating researchers and companies. The results of the project will be disseminated to a wider circle of companies through scientific articles, Medico Bazar 2020, publications, on websites and in newsletters, at workshops and scientific conferences

Aalborg University Project Manager: Charlotte Villadsen, cvi@hst.aau.dk

Aalborg University, Center of Excellence for Osteoarthritis by Aalborg University Hospital and private companies.

Prevention of ankle injuries

Product Compliance early in the innovation project

Ankle injuries are the most frequent sports injury and account for up to 30% of all sports-related injuries. People who are affected experience almost 5 times the risk of future injuries, resulting in an increased risk of developing chronic conditions such as ankle instability and osteoarthritis.

These consequential injuries can result in loss of quality of life and have high costs to society in connection with the costs of diagnosis, treatment and lost labor. The Country Patient Register records more than 40,000 emergency room inquiries annually related to ankle injuries, and it is estimated that these injuries represent an economic community burden of more than DKK 500 million.

Read more about Spraino

Prototype development of a new product that can prevent ankle injuries widely in indoor sports and is used in all indoor sports. In the future, this knowledge and insight could lead to the development of shoes with implemented Spraino technology that can effectively prevent ankle injuries. Seek out the innovation potential of SHFT in damage prevention.

The project will lead to a more comprehensive application to Eurostars with the aim of achieving extended collaboration with leading international research institutions in sports medicine, biomechanics and tribology: Institute of Biomechanics and Orthopedics, German Sport University Cologne, Cologne, Germany Peter Grünberg Institute (PGI ), Forschungszentrum Jülich GmbH, Jülich, Germany.

August 2019 – December 2019. 

More information will follow when the project is initiated.

Technical University of Denmark, Trine Middelbo, tmiso@dtu.dk

Aalborg University and DTU Mechanical Engineering. 

Sport Confederation of Denmark, DGI, Institute of Biomechanics and Orthopedics, German Sport University Cologne.

Private companies.

This project aims at developing simplified and efficient methodologies for regulatory compliance in the early state of product development. However, project partners with products already on the market or with products under development may equally benefit from the activity.

The projects first activity focuses on safe and innovative user interfaces for medical devices secured through mastering Usability Engineering. The second activity is expected to focus on securing environmental sustainability for medical electrical devices.   

Partnering innovative health technology companies will benefit from simplified and efficient yet compliant methodologies developed throughout the project. The partners will, depending on their individual effort, be prepared for assessment towards relevant standards.

The concept and effectiveness of the developed methodologies will be presented in an open forum and/or through articles on-line.

Usability project: October 2019 – April 2020

Sustainability project: April 2020 – December 2020

Innovative health technology companies that have solutions in the field are welcome to contact the project manager.

Usability project: Participation in open workshop in October 8th 2019 – calendar on the website.

Sustainability project: To be defined.

FORCE Technology, Senior Specialist: Morten Kjær Johansen mkjo@force.dk

Private companies.

Estimating Cardiovascular Health Using Seismo Cardiography

Cardiovascular disease is a cause of early death and one of the major causes of morbidity and reduced quality of life. In addition the area is burdening the societal costs of the health sector.

There is considerable scientific evidence that modifying certain risk factors reduces both mortality and morbidity for people with or without diagnosed cardiovascular disease. An improved risk profile and prevention could reduce mortality and improve treatment.

The purpose is to develop a robust method to fully quantify the SCG-signal and to start calculate the risk of cardiovascular disease. The method should be applied to patients with suspected heart failure and used to predict the risk profile of healthy citizens, e.g. via an APP, which can be used on smartphones, enabling the individual citizen to take a risk assessment from home. The companies participating will build knowledge and skills to use advanced risk estimation based on signal processing.

January 2019 – December 2019

A binding cooperation agreement has been signed between the participating researchers and companies. The results of the project will be disseminated to a wider range of companies via Medico Bazar 2020, on websites and newsletters, at scientific conferences and if possible at Good Morning Denmark.

Aalborg University Project Manager: Charlotte Villadsen, cvi@hst.aau.dk

Aalborg University, Aalborg University Hospital and private companies.

Close Menu

Signup for our

Newsletter

Signup for our newsletter and get relevant news from Danish Healthtech, directly in your inbox.